| Literature DB >> 32714418 |
Ramzi Shawahna1,2.
Abstract
BACKGROUND: The current study was performed to develop a consensus-based core inventory of key performance indicators (KPIs) to be used in capturing the impact of pharmaceutical care in healthcare facilities that employ integrative medicine paradigm in Palestine.Entities:
Year: 2020 PMID: 32714418 PMCID: PMC7334769 DOI: 10.1155/2020/7527543
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Flowchart of the different stages of the study.
Sociodemographic and practice characteristics of the Delphi panel members (n = 50).
| Characteristic |
| % |
|---|---|---|
| Gender | ||
| Male | 28 | 56.0 |
| Female | 22 | 44.0 |
| Age (years) | ||
| <40 | 11 | 22.0 |
| ≥40 | 39 | 78.0 |
| Profession | ||
| CAM practitioner | 15 | 30.0 |
| Pharmacist | 15 | 30.0 |
| Physician | 10 | 20.0 |
| Nurse | 7 | 14.0 |
| Risk/quality assurance manager | 3 | 6.0 |
| Academic degree | ||
| B.Sc./Pharm.D. | 22 | 44.0 |
| M.Sc. | 11 | 22.0 |
| MD | 10 | 20.0 |
| Ph.D. | 7 | 14.0 |
| Employer | ||
| Hospital | 25 | 50.0 |
| Private practice | 7 | 14.0 |
| Pharmacy | 6 | 12.0 |
| Educational/training organization | 9 | 18.0 |
| Regulatory body/ministry | 3 | 6.0 |
| Length of practical experience in the domain (years) | ||
| 5–10 | 18 | 36.0 |
| ≥10 | 32 | 64.0 |
B.Sc.: Bachelor of Science; CAM: complementary and alternative medicine; MD: Doctor of Medicine; M.Sc.: Master of Science; Pharm.D.: Doctor of Pharmacy; Ph.D.: Doctor of Philosophy.
Views and opinions of the panel members on the roles of pharmacists in caring for patients admitted to or visiting healthcare facilities that employ integrative medicine.
| # | Statement | Disagree | Neutral | Agree | |||
|---|---|---|---|---|---|---|---|
|
| % |
| % |
| % | ||
| 1 | Pharmacists have the potential to play a crucial role in providing care services to patients who are admitted/visiting integrative healthcare facilities that provide CAM. | 0 | 0.0 | 3 | 6.0 | 47 | 94.0 |
|
| |||||||
| 2 | Interventions of pharmacists can bring significant improvements in care services provided to patients who are admitted/visiting integrative healthcare facilities that provide CAM. | 0 | 0.0 | 7 | 14.0 | 43 | 86.0 |
|
| |||||||
| 3 | Interventions of pharmacists can bring a significant reduction in problems related to medications and CAM prescribed and/or used by patients who are admitted/visiting integrative healthcare facilities that provide CAM. | 2 | 4.0 | 3 | 6.0 | 45 | 90.0 |
|
| |||||||
| 4 | Pharmacists should play an active role in designing the care plans for patients who are admitted/visiting integrative healthcare facilities that provide CAM. | 0 | 0.0 | 3 | 6.0 | 47 | 94.0 |
|
| |||||||
| 5 | Pharmacists should take responsibility and review, evaluate, and when necessary should recommend changes to care plans designed for patients who are admitted/visiting integrative healthcare facilities that provide CAM. | 1 | 2.0 | 3 | 6.0 | 46 | 92.0 |
|
| |||||||
| 6 | Currently, pharmacists are underemployed in providing care for patients who are admitted/visiting integrative healthcare facilities that provide CAM. | 9 | 18.0 | 12 | 24.0 | 29 | 58.0 |
|
| |||||||
| 7 | Interventions by pharmacists have the potential to improve knowledge of patients who are admitted/visiting integrative healthcare facilities that provide CAM with regard to the medications and CAM modalities prescribed to them. | 1 | 2.0 | 3 | 6.0 | 46 | 92.0 |
|
| |||||||
| 8 | Pharmacists should assume an active role in educating patients who are admitted/visiting integrative healthcare facilities that provide CAM about their diseases, medications, and CAM use. | 1 | 2.0 | 2 | 4.0 | 47 | 94.0 |
|
| |||||||
| 9 | Pharmacists should promote and ensure adherence to medication and CAM use among patients who are admitted/visiting integrative healthcare facilities that provide CAM. | 1 | 2.0 | 4 | 8.0 | 45 | 90.0 |
|
| |||||||
| 10 | Interventions of pharmacists can promote adherence of patients who are admitted/visiting integrative healthcare facilities that provide CAM to using their medications and CAM modalities. | 2 | 4.0 | 3 | 6.0 | 45 | 90.0 |
|
| |||||||
| 11 | Interventions of pharmacists can promote the quality of life of patients who are admitted/visiting integrative healthcare facilities that provide CAM. | 3 | 6.0 | 10 | 20.0 | 37 | 74.0 |
CAM: complementary and alternative medicine.
Activities rated by ≥ 60% of the panel members in the first Delphi round as potential key performance indicators (KPIs).
| # | Activities | First Delphi round |
|---|---|---|
| % of panel members who rated the activity as potential KPI | ||
| 1 | Number of best possible medications histories taken | 88.0 |
| 2 | Number of best possible CAM histories taken | 84.0 |
| 3 | Number of best possible medications history reviews conducted | 86.0 |
| 4 | Number of best possible CAM history reviews conducted | 84.0 |
| 5 | Number of medication reconciliations at admission conducted | 76.0 |
| 6 | Number of medication reconciliations at transition (between wards/services/hospitals) of care conducted | 74.0 |
| 7 | Number of medication reconciliations at discharge conducted | 72.0 |
| 8 | Number of CAM reconciliations at admission conducted | 72.0 |
| 9 | Number of CAM reconciliations at transition (between wards/services/hospitals) of care conducted | 70.0 |
| 10 | Number of CAM reconciliations at discharge conducted | 74.0 |
| 11 | Number of identified/resolved discrepancies/problems related to medications | 80.0 |
| 12 | Number of identified/resolved discrepancies/problems related to CAM | 76.0 |
| 13 | Number of collaborative, direct, and comprehensive patient care services provided | 72.0 |
| 14 | Number of therapeutic care plans developed/prepared/implemented/completed | 74.0 |
| 15 | Number of interprofessional discussions initiated/participated in | 62.0 |
| 16 | Number of suggestions accepted by other healthcare professionals like physicians | 60.0 |
| 17 | Number of meetings attended | 60.0 |
| 18 | Number of patient education sessions conducted | 68.0 |
| 19 | Number of formal inquiries answered | 66.0 |
| 20 | Number of medication orders reviewed | 74.0 |
| 21 | Number of CAM orders reviewed | 72.0 |
| 22 | Number of medication monitoring ordered/followed up/reviewed | 60.0 |
| 23 | Number of CAM monitoring ordered/followed up/reviewed | 60.0 |
| 24 | Number of contraindications related to medications identified/resolved | 80.0 |
| 25 | Number of contraindications related to CAM identified/resolved | 82.0 |
| 26 | Number of allergies to medications identified/resolved | 84.0 |
| 27 | Number of allergies to CAM identified/resolved | 84.0 |
| 28 | Number of drug-drug interactions identified/resolved | 88.0 |
| 29 | Number of drug-food interactions identified/resolved | 78.0 |
| 30 | Number of drug-CAM interactions identified/resolved | 84.0 |
| 31 | Number of CAM-CAM interactions identified/resolved | 80.0 |
| 32 | Number of CAM-food interactions identified/resolved | 78.0 |
| 33 | Number of inappropriate medication doses to the patient's renal function identified/resolved | 64.0 |
| 34 | Number of inappropriate CAM doses to the patient's renal function identified/resolved | 62.0 |
| 35 | Number of medication underdoses identified/resolved | 62.0 |
| 36 | Number of CAM underdoses identified/resolved | 60.0 |
| 37 | Number of medication overdoses identified/resolved | 66.0 |
| 38 | Number of CAM overdoses identified/resolved | 64.0 |
| 39 | Number of medication doses titrated to produce a desirable therapeutic effect | 60.0 |
| 40 | Number of CAM doses titrated to produce a desirable therapeutic effect | 60.0 |
| 41 | Number of adverse drug reactions identified/resolved | 72.0 |
| 42 | Number of adverse CAM reactions identified/resolved | 70.0 |
| 43 | Number of duplicate medications identified/resolved | 66.0 |
| 44 | Number of duplicate CAMs identified/resolved | 64.0 |
| 45 | Number of ineffective medications identified/resolved | 62.0 |
| 46 | Number of ineffective CAMs identified/resolved | 62.0 |
| 47 | Number of ambiguous medication orders identified/resolved | 66.0 |
| 48 | Number of ambiguous CAM orders identified/resolved | 64.0 |
| 49 | Number of misspelled medication orders identified/resolved | 60.0 |
| 50 | Number of misspelled CAM orders identified/resolved | 60.0 |
| 51 | Number of illegibly written medication orders identified/resolved | 60.0 |
| 52 | Number of illegibly written CAM orders identified/resolved | 62.0 |
| 53 | Number of missing medications (that should have been prescribed) identified/resolved | 66.0 |
| 54 | Number of missing CAMs (that should have been prescribed) identified/resolved | 64.0 |
| 55 | Number of missing medication doses identified/resolved | 78.0 |
| 56 | Number of missing CAM doses identified/resolved | 76.0 |
| 57 | Number of missing medication frequencies of administration identified/resolved | 74.0 |
| 58 | Number of missing CAM frequencies of administration identified/resolved | 76.0 |
| 59 | Number of missing medication routes of administration identified/resolved | 72.0 |
| 60 | Number of missing CAM routes of administration identified/resolved | 76.0 |
| 61 | Number of missing medication durations of therapy identified/resolved | 74.0 |
| 62 | Number of missing CAM durations of therapy identified/resolved | 72.0 |
| 63 | Number of missing recommendations to take medications in relation to meal identified/resolved | 68.0 |
| 64 | Number of missing recommendations to take CAM in relation to meal identified/resolved | 66.0 |
| 65 | Number of medication-related problems for high alert medications identified/resolved | 80.0 |
| 66 | Number of CAM-related problems for highly toxic CAM identified/resolved | 78.0 |
| 67 | Number of documented assessments of response to a therapeutic plan involving medications initiated/implemented/completed | 62.0 |
| 68 | Number of documented assessments of response to a therapeutic plan involving CAM initiated/implemented/completed | 60.0 |
| 69 | Number of complaints on the services of pharmacists and CAM practitioners received | 60.0 |
| 70 | Number of errors related to medications committed | 66.0 |
| 71 | Number of errors related to CAM committed | 64.0 |
| 72 | Number of continuing educational/training sessions attended | 60.0 |
| 73 | Number of educational/training sessions delivered | 60.0 |
CAM: complementary and alternative medicine.
The consensus-based key performance indicators.
| # | KPI | Second Delphi round | Third Delphi round | Thematic area | ||||
|---|---|---|---|---|---|---|---|---|
| M | IQR | % of panel members who rated the KPI 7–9 | M | IQR | % of panel members who rated the KPI 7–9 | |||
| 1 | Number of medication and/or CAM related problems identified and addressed/resolved by pharmacists including contraindications, inappropriate doses (over- and/or underdoses), allergies, interactions, duplications, omissions, vague/ambiguous orders, inappropriate routes of administration, inappropriate duration of therapy, and reported ineffective therapies. | 8.0 | 3.0 | 60.0 | 9.0 | 1.0 | 90.0 | Care |
|
| ||||||||
| 2 | Number | 8.0 | 3.5 | 62.0 | 8.0 | 1.0 | 88.0 | Reconciliation |
|
| ||||||||
| 3 | Number | 7.0 | 3.5 | 60.0 | 8.0 | 2.0 | 86.0 | Care |
|
| ||||||||
| 4 | Number | 6.5 | 3.5 | 58.0 | 7.5 | 2.0 | 84.0 | Care |
|
| ||||||||
| 5 | Number | 6.5 | 4.0 | 56.0 | 7.0 | 1.0 | 82.0 | Counseling/education |
|
| ||||||||
| 6 | Number of written complaints on the services delivered by pharmacists received per a predefined period of time. | 6.0 | 4.0 | 52.0 | 7.0 | 1.0 | 80.0 | Competence/performance/satisfaction |
|
| ||||||||
| 7 | Number of errors committed by pharmacists per a predefined period of time. | 5.5 | 4.0 | 50.0 | 7.0 | 1.0 | 78.0 | Competence/performance/satisfaction |
|
| ||||||||
| 8 | Number of multi-healthcare provider discussions/deliberations for the purpose of improving care of patients in which pharmacists actively participated and contributed including answering formal inquiries by other healthcare providers. | 5.5 | 4.0 | 48.0 | 7.0 | 0.0 | 76.0 | Multi-healthcare provider patient care |
Or percentage out of the total number of patients who were admitted/visited/received care in the healthcare facility per a predefined period of time. CAM: complementary and alternative medicine; IQR: interquartile range; KPI: key performance indicator; M: median.
The candidate activities and services that consensus was not achieved to consider them as key performance indicators.
| # | KPI | Second Delphi round | Third Delphi round | Thematic area | ||||
|---|---|---|---|---|---|---|---|---|
| M | IQR | % of panel members who rated the KPI 7–9 | M | IQR | % of panel members who rated the KPI 7–9 | |||
| 1 | Number of continuing education/training sessions attended/delivered by pharmacists per a predefined period of time. | 6.0 | 4.5 | 44.0 | 6.0 | 4.0 | 54.0 | Professional development |
|
| ||||||||
| 2 | Number of therapeutic monitoring orders for medications/CAM ordered/followed up/reviewed by pharmacists per a predefined period of time. | 5.5 | 5.0 | 42.0 | 6.0 | 3.5 | 46.0 | Care |
|
| ||||||||
| 3 | Number of high-risk medication/CAM regimens assessed and followed up for therapeutic response by pharmacists on defined intervals. | 5.0 | 5.0 | 40.0 | 5.5 | 3.0 | 44.0 | Care |
IQR: interquartile range; KPI: key performance indicator; M: median.